Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 124378
Published online Nov 27, 2026. doi: 10.4240/wjgs.124378
Published online Nov 27, 2026. doi: 10.4240/wjgs.124378
Table 1 Comparison of conventional liver-containing multivisceral transplantation and modified liver-sparing multivisceral transplantation
| Feature | Conventional liver-containing MVT | Modified liver-sparing MVT |
| Immunoprotective effect | +++ (with liver-mediated immunoprotection) | - (absent) |
| Risk of rejection | Lower | Higher |
| Requirement for donor liver | Required | Not required |
| Main indications | Intestinal failure with end-stage liver disease | Intestinal failure with preserved liver function |
| Intensity of immunosuppression | May be moderately reduced | High-intensity immunosuppression generally required |
| Ref. | [27] | [24,28] |
- Citation: Zhao ZW, Chen YG, Wang GY. Mechanisms, clinical translation, and future perspectives of liver-mediated immunoprotection in combined organ transplantation. World J Gastrointest Surg 2026; 18(11): 124378
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/124378.htm
- DOI: https://dx.doi.org/10.4240/wjgs.124378